Treatment of Advanced Grade III Periodontal Furcation Lesions
Clinical- and Patient-reported Outcomes Following Treatment of Grade III Furcation-involved Molars. A Single-centre Single-masked Randomised Controlled Feasibility Trial With SMART Design.
1 other identifier
interventional
20
1 country
1
Brief Summary
Periodontitis, a microbially-driven inflammatory disease has been shown to be the sixth most common disease of mankind. The 2009 UK Adult Dental Health Survey found that 54% of adults experience gum bleeding (gingivitis) with 45% of these suffering from periodontitis. Periodontitis begins at the gingival margins of teeth and over time, in susceptible individuals, the presence of a plaque biofilm can lead to the loss of the supporting connective tissue and alveolar bone associated with the teeth. This leads to the formation of a pathological periodontal pocket between the gingiva and tooth root, measurable by the use of a periodontal probe and recorded as the probing pocket depth (PPD). The associated loss of alveolar bone support is measurable radiographically and often leads to tooth mobility and if allowed to persist, can eventually lead to tooth loss. Periodontitis is classified into 4 stages (I-IV) based on disease severity and 3 grades (A-B-C) based on risk of disease progression. The treatment of periodontitis involves a non-specific reduction of the bacterial load below the gingival margin. This is achieved by effective oral hygiene procedures and non-surgical periodontal therapy (NSPT), both of which are aimed at the removal of calculus (tartar) deposits and the disruption of the plaque biofilm from the affected root surfaces. In some cases, this treatment may then be followed by more invasive treatments such as periodontal surgery and if successful, patients can then be followed and maintained with supportive periodontal maintenance therapy (SPT). It should be noted that certain periodontal lesions in some patients do not however always respond favourably to treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2022
CompletedStudy Start
First participant enrolled
February 5, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFebruary 6, 2024
February 1, 2024
2.1 years
January 24, 2022
February 5, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Number of patients
Number of participants recruited and retained into the study
13 months
Number of responsive and non-responsive
Number of participants deemed responsive and non-responsive to different treatments. Questionnaire will be used to assess the responsiveness to each treatment.
13 months
Number of participants randomised
Number of participants willing to be randomised to treatment II of the study (if deemed non-responsive following treatment I). Yes or Not answer to randomisation will be used to assess this number.
13 months
patient-reported outcomes (Pros)
A self-administered questionnaire will be used to assess the patient-reported outcomes (PROS) at 6 and 12 months based on different treatment arms
13 months
Probing Pocket Depth (PPD)
Distance between gingival margin and the bottom of the pocket, measured in mm
13 months
Bleeding on probing (BOP)
Bleeding after probing with the periodontal probe the gingival margin, 0 no bleeding 1 bleeding.
13 months
Secondary Outcomes (1)
Microbiological analysis
13 months
Study Arms (2)
Test Group
EXPERIMENTALTen participants will be randomised to receive surgical periodontal treatment in the form of open flap debridement (OFD).
Control Group
ACTIVE COMPARATORTen participants will be randomised to receive non-surgical periodontal treatment (NSPT). All treatment will be carried out by the same therapist, including oral hygiene.
Interventions
Participants will receive local anesthesia. Thorough debridement of the root surface will be completed to the depth of the periodontal pocket and of the furcation lesion, by using piezo-electric/ultrasonic devices with specific thin and delicate tips (such as Cavitron, Dentsply Sirona, US) and/or curettes. Treatment chair time will be recorded for each visit.
Patients will receive local anesthesia and intrasulcular incisions will be made by buccal and lingual/palatal aspects in order to reflect full-thickness flaps. After reflection of the flaps, the granulation tissue around the tooth will be removed with the non-cutting edge of a suitable scaling instrument such as a curette, taking care not to damage the root surfaces. Thorough debridement of the furcation area will be carried out by using piezo-electric/ultrasonic devices with specific thin and delicate tips
Eligibility Criteria
You may qualify if:
- Age 18-70
- Diagnosis of Periodontitis stage III or IV, grade A, B or C
- At least one maxillary or mandibular molars with:
- Furcation involvement grade III horizontal classification degree B-C vertical classification without any ongoing restorative problems as judged by the study clinician)
- Probing depth ≥ 6mm
- Mobility \< degree II (as examined by the study clinician)
- Absence of any ongoing endodontic pathology (as examined by the study clinician)
- Absence of an adjacent tooth with unfavorable periodontal prognosis (as judged by the study clinician)
- Non-surgical periodontal therapy performed to the study site within the last 6 months.
- Able to consent to study participation
You may not qualify if:
- Smoking (any current or in past 5 years)
- Medical history including diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases
- History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
- Anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam
- Systemic antibiotic therapy during the 3 months preceding the baseline exam
- History of alcohol or drug abuse
- . Self-reported pregnancy or lactation
- Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that according to the investigator may increase the risk associated with trial participation
- Previous surgical periodontal performed to the study site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King's College London
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luigi Nibali
Floor 18, Tower Wing Guy's Hospital London SE1 9RTN/A
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Simple randomisation will be completed using the online programme, Sealed Envelope. This will be completed by a member of the research team not involved in this specific study. Sealed Envelope will provide a randomisation schedule, patient numbering and a sequence of patient number assignment. This will all be safely stored and secured. The treatment allocation will be communicated to the study therapist/nurse and patient when booking the treatment appointment. It will not be possible to blind the participants or the clinician completing the study treatment. The study examiner will remain blind to treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2022
First Posted
February 14, 2022
Study Start
February 5, 2022
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
February 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share